Open Close

Oracle teams with Nuance to voice enable clinical trials

Oracle (NYSE: ORCL) reported that Oracle Health Sciences will work with Nuance Communications(NASDAQ: NUAN) to help simplify and accelerate data collection and management for clinical trials through state-of-the-art voice-to-text capabilities for web-based apps and mobile devices.

Oracle and Nuance said they expect to work together to integrate Nuance technology with Oracle e-clinical software.

Together, the technologies will help simplify, streamline and speed electronic data capture, mobile data capture and data review by clinical data entry staff, investigators and clinical research associates.

By accelerating capture and review of trial-related data, health sciences organizations can speed time-to-data lock, improve risk based monitoring solutions and help to reduce costs.

Oracle Health Sciences delivers comprehensive business applications, plus database, middleware, and hardware solutions for life sciences and healthcare companies and institutions worldwide. For more information, visit

Nuance Communications is a provider of voice and language solutions for businesses and consumers around the world. For more information, visit:


If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.